http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#Head
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#assertion
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#provenance
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#pubinfo
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#assertion
http://purl.obolibrary.org/obo/DOID_5408
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_5408
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00017
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
http://www.w3.org/2000/01/rdf-schema#label
miacalcin synthetic injection is a calcitonin indicated for the following conditions 1 1 1 2 1 3 limitations of use 1 4 5 3 miacalcin injection is indicated for the treatment of symptomatic paget s disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphatase and urinary hydroxyproline excretion there is no evidence that the prophylactic use of calcitonin salmon is beneficial in asymptomatic patients miacalcin injection should be used only in patients who do not respond to alternative treatments or for whom such treatments are not suitable e g patients for whom other therapies are contraindicated or for patients who are intolerant or unwilling to use other therapies miacalcin injection is indicated for the early treatment of hypercalcemic emergencies along with other appropriate agents when a rapid decrease in serum calcium is required until more specific treatment of the underlying disease can be accomplished it may also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide oral phosphate or corticosteroids or other agents miacalcin injection is indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause the evidence of efficacy for calcitonin salmon injection is based on increases in total body calcium observed in clinical trials fracture reduction efficacy has not been demonstrated miacalcin injection should be reserved for patients for whom alternative treatments are not suitable e g patients for whom other therapies are contraindicated or for patients who are intolerant or unwilling to use other therapies due to the possible association between malignancy and calcitonin salmon use the need for continued therapy should be re evaluated on a periodic basis see warnings and precautions 5 3
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/SymptomaticReliefIndication
https://identifiers.org/drugbank:DB00017
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#provenance
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#pubinfo
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#sig
http://purl.org/nanopub/x/hasSignature
ZwVKNMgXrw/NqPCLS8Ua6i7XDgoL4uatJ0MhV7IOdBog7/10WprCY4rvNqds3jQeMsYTaE+Y6Db14TwXsVOlu/MExP01F2kz53uFWT+lvmW8CZEKJsEr0X/Io61+41LY3CFmuj/JPEi2oV0qOuHZW1Jt+lvVBQM34RFjn70lEMw=
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
http://purl.org/dc/terms/created
2021-06-27T20:30:46.335+02:00
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAUaV8d5ePgHMiX1uYCXhMR6Xx5_rbO_Q3Uy5ghcwuKmQ
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs